Company news
Gsk Plc (LSE:GSK) news
Gsk Plc news releases on 6ix. Latest, Oct 6, 2026: Admission to Trading
Press releases & updates
Admission to Trading
October 6, 2026
Total Voting Rights
October 1, 2026
GSK : to acquire potential best-in-class T cell-engager (TCE) for multiple myeloma from Chimagen Biosciences
September 15, 2026
Jideytro positive data for ROS1-positive NSCLC
September 14, 2026
GSK : presents positive registrational data to potentially expand Jideytro (zidesamtinib) to first-line ROS1-positive non-small cell lung cancer
September 13, 2026
GSK : Ris-Rez reduced risk of death by 54% versus topotecan in patients with relapsed small cell lung cancer in China
September 12, 2026
Japan approval of Shingrix in a prefilled syringe
September 10, 2026
mRNA flu vaccine candidate to advance to phase III
September 1, 2026
GSK appoints Tina Graves as President & General Manager, Canada
August 26, 2026
GSK : Hibsago (bepirovirsen) approved in Japan as first and only functional cure for chronic hepatitis B
August 24, 2026
GSK's Blenrep (belantamab mafodotin) combinations approved in Singapore for treatment of relapsed/refractory multiple myeloma
August 18, 2026
Nucala (mepolizumab) receives a positive reimbursement recommendation from CDA-AMC for adults with chronic obstructive pulmonary disease (COPD)
August 18, 2026
Cabenuva demonstrates superiority to daily oral therapy in adolescents living with HIV, as ViiV Healthcare highlights new long-acting injectable data at AIDS 2026
July 29, 2026
GSK : delivers strong Q2 core results performance and continued momentum. Plans announced to accelerate R&D and late-stage pipeline portfolio. Expect 20+ phase III trial starts in 2026
July 28, 2026
New survey reveals Canadians underestimate chronic hepatitis B and its link to liver cancer
July 28, 2026
ViiV Healthcare’s 2-drug regimen Dovato is as effective as 3-drug regimen Biktarvy in first-of-its-kind head-to-head study in treatment-naïve adults living with HIV
July 27, 2026
GSK's Shingrix (Recombinant Zoster Vaccine) prefilled syringe presentation approved in Canada
July 24, 2026
GSK plc - Jideytro approved in the US for previously treated ROS1-positive non-small cell lung cancer
July 23, 2026
Jideytro (zidesamtinib) approved in the US for previously treated ROS1-positive non-small cell lung cancer
July 22, 2026
ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults; alongside INSTI-powered long-acting injectable innovation at AIDS 2026
July 21, 2026
GSK : European Medicines Agency accepts submission to update Bexsero label for 1-dose Meningitis B booster in 10+ year olds
July 20, 2026
GSK : provides an update on CALM-1 and CALM-2 phase III trials for camlipixant in refractory chronic cough (RCC)
July 17, 2026
GSK : completes acquisition of Nuvalent, Inc.
July 15, 2026
GSK : Jemperli (dostarlimab) achieves sustained clinical complete responses in dMMR/MSI-H locally advanced rectal cancer
July 13, 2026
GSK : licensor Hansoh Pharma announces positive phase III results for Ris-Rez in China patient population
July 10, 2026
GSK : Roy Jakobs to join GSK Board as Non-Executive Director
July 9, 2026
GSK announces tender offer to acquire Nuvalent
June 24, 2026
Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)
June 17, 2026
GSK : Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)
June 17, 2026
Momelotinib orphan drug designations for VEXAS
June 12, 2026
The Franklin Institute and GSK Celebrate 40 Years of GSK Science in the Summer™ with New "Be A Chemist!" Theme and Program Expansion
June 10, 2026
The Biotech Growth Trust PLC - GSK plc to acquire BIOG portfolio company, Nuvalent, Inc.
June 9, 2026
Nucala (mepolizumab) approved in Canada for use in adults with chronic obstructive pulmonary disease (COPD)
June 1, 2026
Ionis partner GSK announces bepirovirsen achieves unprecedented functional cure rates with potential to redefine treatment for chronic hepatitis B
May 28, 2026
GSK : to showcase long-term outcomes and pipeline expansion with latest oncology research at ASCO and EHA
May 26, 2026
Q2 2026 Results Date Confirmed - 28 July 2026
May 22, 2026
Japan MHLW approves Arexvy for adults 18-49 AIR
May 18, 2026
Benlysta Sales Forecast and Market Size Analysis Report 2026-2034 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan
May 15, 2026
Collaboration with CTTQ for bepirovirsen
May 11, 2026
GSK : 2026 Remuneration Policy
May 6, 2026
GSK : presents latest respiratory research to advance patient care at ATS 2026
May 6, 2026
GSK : Q1 2026 results transcript
April 30, 2026
Q1 results lower year on year, as expected; Comprehensive action plan underway to address market challenges
April 29, 2026
Human Papillomavirus Market Research Report 2025-2035, Competitive Analysis of Key Players - GlaxoSmithKline, Merck, and Serum Institute of India
April 28, 2026
Efimosfermin granted US/EU regulatory designations
April 27, 2026
Blenrep approved in China for 2L+ multiple myeloma
April 20, 2026
GSK completes acquisition of 35Pharma Inc.
April 15, 2026
GSK presents positive data for BEHOLD 1 B7 H4 ADC
April 13, 2026
GSK : presents positive data for B7-H4-targeted ADC in gynaecological cancers
April 12, 2026
The Time to Talk about HIV is Now: ViiV Healthcare Launches "Still Here" PSA to Ignite Action Around HIV on National Youth HIV/AIDS Awareness Day
April 10, 2026